Smithsonian museums continue to be closed to support the effort to contain the spread of COVID-19. Read a message from our director, and check our website and social media for updates.



Usage conditions apply
This conical–shaped wooden drug jar and lid has an ivory–colored shield outlined in black. The wood is slightly warped and the lid does not separate from the container. The interior of the shield is marked, "OLIBAN:” in black paint. Olibanum—also known as frankincense—is a yellow–brown resin from the Boswellia Scara tree. Known for millennium in the Middle East, Oliban is still used as incense in religious ceremonies and as an ingredient in perfumes. As a medicine, it was used as a stimulant to promote sweating. It was also used as a laxative.
Containers 1991.0664.0889 through 892 appear to be from the same apothecary. The Deutsche Apotheken-Museum in Heidelberg, Germany has similar containers in their collection.
Currently not on view
Object Name
date made
19th Century
place made
Physical Description
turnen wood (overall production method/technique)
wood (overall material)
paint (overall material)
overall: 13.3 cm x 7.1 cm; 5 1/4 in x 2 25/32 in
ID Number
catalog number
accession number
collector/donor number
SAP 814
catalog number
Credit Line
Gift of American Pharmaceutical Association and Bristol-Myers Squibb Company
See more items in
Medicine and Science: Medicine
Health & Medicine
European Apothecary
Data Source
National Museum of American History
Nominate this object for photography.   

Our collection database is a work in progress. We may update this record based on further research and review. Learn more about our approach to sharing our collection online.

If you would like to know how you can use content on this page, see the Smithsonian's Terms of Use. If you need to request an image for publication or other use, please visit Rights and Reproductions.

Note: Comment submission on our collection pages is temporarily unavailable. Please check back soon!

If you have a question or require a personal response, please visit our FAQ or contact page.